HRA009965
Title:
Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test
Release date:
2025-01-09
Description:
We prospectively recruited 116 lymphoma patients from two clinical centers, and collected blood samples at pre-treatment (baseline) and after two treatment cycles (landmark) to calculate molecular tumor burden (MTB) score using SeekInClarity.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cohort Study
Disease name:
lymphoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Seekin DAC
Contact person:
lee shiyong
Email:
lishiyonglee@gmail.com
Description:
Standardize the storage and usage of internal project data to ensure data security.
Individuals & samples
Submitter:   Mao Mao / maomao@seekin.onaliyun.com
Organization:   Shenzhen SeekIn Inc
Submission date:   2024-12-31
Requests:   -